- Home
- App Analytics
- iMolecular Builder for iPad
iMolecular Builder for iPad app analytics for December 19
iMolecular Builder for iPad
- song hyunsub
- Apple App Store
- Paid
- Productivity
The iMoleBuilder is an application that can view, edit and build molecules in 3D.
Users can easily analyze a molecular structure by rotating, moving, and zooming it.
[Support file format]
PDB : Protein Data Bank format(*.pdb)
MOL : MDL Mole files(.mol)
XYZ : XYZ cartesian coordinates(*.xyz)
MOL2: Sybyl Mol2 format(*.mol2)
CIF : Crystallographic Information
RES : ShelX format [Read-only]
SMO : Save all molecular information(include cell, surface, measure information) and view window information(scale, rotation, etc.) (*.smo)
[Open & Save]
Device
FTP Server
Web(Open only)
Email(Open an email attachment)
SMole(iMoleBuilder for Windows - You can download from IMoleBuilder Support page for free.)
[View style]
Line, Ball, Stick, Ball & Stick, Scaled Ball, Solvent.
Surface, Ribbon, Cartoon, Tube, Trace.
[Work Tool]
Cursor tool, Info tool, Add tool, Delete tool, Measure tool.
[Builder]
Molecular Builder , Crystal Builder, Surface Builder, Carbon Nanotube Builder
[Measure]
Coordinate, Length, Angle, Torsion information.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Productivity in
United States--
Create an account to see avg.monthly downloadsContact us
iMolecular Builder for iPad Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for iMolecular Builder for iPad
Rank
No Data Available
iMolecular Builder for iPad Ranking by Country
Counties in which iMolecular Builder for iPad has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
NoteShot: Notion Image to Text
ANCIENDA TEKNOLOJI YAZILIM VE PAZARLAMA ANONIM SIRKETI
Print n Share
EuroSmartz Ltd
iDesign
TouchAware Limited
Notes Plus
Viet Tran
iMolecular Builder for iPad VS.
December 19, 2024